• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : Allergic Bronchopulmonary Aspergillosis

Allergic Bronchopulmonary Aspergillosis - 16 Studies Found

Completed : Trial on the Efficacy and Safety of Two Different Glucocorticoid Dose Regimens in Allergic Bronchopulmonary Aspergillosis
:
: 2025-07-30
Active, not recruiting : Protocol TARC-ABPA
: Allergic Broncho-Pulmonary Aspergillosis
: 2012-10-15
: Other: Study of predictive factors Phase 1 : Inclusion of
Completed : Voriconazole Versus Oral Steroids in Allergic Bronchopulmonary Aspergillosis
: Allergic Bronchopulmonary Aspergillosis
: 2012-06-12
:
  • Drug: Prednisolone Prednisolon

Not yet recruiting : A Study Evaluating Vitamin D in Allergic Bronchopulmonary Aspergillosis Complicating Asthma
: Allergic Bronchopulmonary Aspergilloses
: 2017-04-21
:
  • Drug: Glucocorticoids Oral pre

Completed : A Randomized Trial of Itraconazole in Acute Stages of Allergic Bronchopulmonary Aspergillosis
: Allergic Bronchopulmonary Aspergillosis
: 2015-05-01
:
  • Drug: Itraconazole Oral itraco

Completed : Monotherapy of Itraconazole Versus Prednisolone in Allergic Bronchopulmonary Aspergillosis
: Allergic Bronchopulmonary Aspergillosis
: 2011-03-23
:
  • Drug: Glucocorticoids Predniso

Completed : A Randomized Controlled Trial of Inhaled Amphotericin B for Maintaining Remission in Allergic Bronchopulmonary Aspergillosis
: Allergic Bronchopulmonary Aspergillosis
: 2013-05-13
:
  • Drug: Inhaled budesonide The c

Completed : Open-label Vitamin D Trial for Patients With Cystic Fibrosis and Allergic Bronchopulmonary Aspergillosis
:
  • Cystic Fibrosis
  • Allergic Bronchopulmonary Aspergillosis
  • : 2010-10-14
    : Dietary Supplement: cholecalciferol (Vitamin D3) 4,000 IU of cholecalciferol (Vitamin D3) orally every d
Enrolling by invitation : Evaluation of a Therapeutic Strategy Including Nebulised Liposomal Amphotericin B (Ambisome®) in Maintenance Treatment of Allergic Bronchopulmonary Aspergillosis (Cystic Fibrosis Excluded).
: Allergic Bronchopulmonary Aspergillosis
: 2014-10-22
:
  • Drug: Liposomal amphotericin B (Ambisome®)

Completed : Mechanisms of Immune Tolerance and Inflammation in Patients With Cystic Fibrosis With ABPA
:
  • Cystic Fibrosis
  • Allergic Bronchopulmonary Aspergillosis
  • : 2008-01-01
Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.